Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Composite end points to assess delay of disability progression by MS treatments.
T Cell Epitope Redundancy: Cross-conservation of the TCR face between Pathogens and Self and its Implications for Vaccines and Auto-immunity.
Coexistence of Multiple Sclerosis and Ankylosing Spondylitis: Report of Two Cases.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Marijuana Legalization: Impact on Physicians and Public Health.
Csf analysis and the diagnosis of neuromyelitis optica.
Walking Distance as a Predictor of Falls in People With Multiple Sclerosis.
Effects of a Tailored Positive Psychology Intervention on Well-being and Pain in Individuals with Chronic Pain and a Physical Disability: A Feasibility Trial.
A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
Teriflunomide.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
[Animal model of neuromyelitis optica].
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model.
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
Treatment of sleep disorders may improve fatigue in multiple sclerosis.
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Multiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods.
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »